TCTR20200121005已完成3 期
A randomized, double-blinded, split face clinical study of the efficacy of using Eucerin hyaluron-filler first serum moisture booster as pre serum in increasing skin hydration, increasing skin elasticity and reducing wrinkle
Dermatology division, Department of internal medicine, King Chulalongkorn Memorial Hospital0 个研究点目标入组 23 人开始时间: 2020年1月21日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 23
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 35 Years 至 50 Years（—）
- 性别
- Female
入选标准
- •1.Healthy female volunteers aged 35-50 years old with mild to moderate wrinkle and dryness
- •2.Volunteers who have well adherence and can be followed up as appointed
排除标准
- •1.Volunteers who won't stop using their current treatment ( topical treatment for 2 weeks, Light or laser therapy for 3 months)
- •2.Volunteers who won't use the creams that researcher provided
- •3.Female volunteers who is currently using OCP, pregnancy or breastfeeding
- •4.Volunteers who have psychiatric problems
研究者
相似试验
尚未招募
2 期
A randomized, double-blind, split-faced study comparing A.I. Clearing Treatment with 0.1% adapalene versus 0.1% adapalene in treatment of mild to moderate degree acne vulgarismild to moderate degree acne vulgarisacne vulgarisadapaleneglycolic acidsalicylic acidgluconolactonelicochalcone AmoistureA.I. Clearing TreatmentacneTCTR20171031005Beiersdorf (Thailand) Co., Ltd.25
已完成
4 期
Randomized, double-blind, split-side, comparison study of moisturizer containing MAS064D and 1% hydrocortisone in the treatment of infantile seborrheic dermatitisseborrheic dermatitischildren less than 1 year oldseborrheic dermatitisMAS064Dƹ% hydrocortisone,efficacy,TCTR20160819001A.Menarini (Thailand) Limited50
招募中
3 期
Randomized, Split-Side, Double Blinded, Placebo-Controlled study, the Efficacy of Intralesional Injection of Botulinum Toxin Type A versus 0.9% NaCl for the Treatment of Scalp Psoriasis-Psoriasis with scalp involvementBotulinum toxinOnabotulinum toxinScalp psoriasisScalp-modified Psoriasis Area and Severity IndexTCTR20181214001The Royal College Physicians of Thailand18
进行中（未招募）
不适用
A partially randomized, partially double-blind, placebo-controlled Phase II non-inferiority study to evaluate immunogenicity and safety of one and two doses of MVA-BN (IMVAMUNE™) smallpox vaccine in 18-55 year old healthy subjectsHealthy subjects - prevention of smallpox infectionMedDRA version: 8.0Level: PTClassification code 10041197EUCTR2005-001781-14-DEBavarian Nordic A/S800
尚未招募
3 期
A paired, randomized, double-blind, placebo-controlled trial of EMLA cream (eutectic mixture of local anesthetics) for primary localized cutaneous amyloidosis.primary localized cutaneous amyloidosissymmetryboth legsprimary localized cutaneous amyloidosislichen amyloidosusEMLAtopical anestheticitchpruritusTCTR20170928005none15